For years, scientists have thought that TGF-Beta, a signaling protein that holds sway over an astonishing array of cellular processes from embryonic development to cancer, could only do its work once ...
Transforming growth factor beta 1 (TGFB1), also known as TGF-β1, CED, DPD1, and TGFB, is a polypeptide member of the transforming growth factor beta superfamily of cytokines. It is a secreted protein ...
Zacks Investment Research on MSN
Keros Therapeutics vs. Dyne: Which DMD biotech has more upside?
Keros Therapeutics KROS is a clinical-stage biopharmaceutical company developing innovative therapies for patients with ...
Transforming Growth Factor Beta (TGF‐β) signalling pathways are integral to a wide array of cellular processes, ranging from embryonic development to tissue homeostasis and immune regulation. TGF‐β ...
TCGFB, a private biotech founded by healthcare VC The Column Group, is tapping California biotech Surrozen to discover antibodies for idiopathic pulmonary fibrosis, according to a Nov. 4 release.
Investigating the association of WNT pathway dysregulation and young-onset colorectal cancer. This is an ASCO Meeting Abstract from the 2024 ASCO Gastrointestinal Cancers Symposium. This abstract does ...
Role of Transforming Growth Factor Beta in Human Cancer . If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results